AMR SVG Icons location

Managing Trace Elements in Parenteral Nutrition

A new website providing educational content and treatment guidelines

Explore Now

Dedicated to Alleviating Drug Shortages

We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.

Learn more

Check Product Availability

Updated July 15, 2024

View All
HydrALAZINE Hydrochloride  Vial Image

HydrALAZINE Hydrochloride

  • 20 mg/mL | 1 mL Single Dose Vial
  • Shelf Pack — 25
Papaverine HCL  Vial Image

Papaverine HCL

  • 30 mg/mL | 2 mL Single Dose Vial
  • Shelf Pack — 25
Zinc Sulfate  Vial Image

Zinc Sulfate

  • 5 mg/mL | 5 mL Pharmacy Bulk Package Vial
  • Shelf Pack — 25

News Center

American Regent Introduces Sodium Phosphates Injection, USP; FDA-Approved and “AP” Rated

Shirley, NY – July 2, 2024:
American Regent announces the launch and availability of Sodium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Sodium Phosphates.

American Regent Receives 2023 Novaplus Program Excellence Award from Vizient

Shirley, NY – September 27, 2023:
American Regent has received a Novaplus Program Excellence Award from Vizient, Inc., the nation’s largest provider-driven health care performance improvement company. The recognition was announced at the 2023 Vizient Connections Summit, held September 18-21 in Las Vegas.

INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

Basking Ridge, NJ and Shirley, NY – June 5, 2023: Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity.

Contact Us

Request for Medical Information Request a Grant Investigator Initiated Study Request a Certificate of Analysis Expanded Access Policy
Please choose your preferred method of contact

By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent® database, please submit a message request to corpcommunications@americanregent.com.